Form 4 Lineage Cell Therapeutics Inc For: 2 July By Investing.com
This article announces the filing of Form 4 for Lineage Cell Therapeutics Inc. on July 2nd. It is a brief, one-line announcement from Investing.com, accompanied by current market data for various indices, commodities, and stocks. The content also includes popular news headlines and market movers.
Form 4 Northern Trust Corporation For: 2 July By Investing.com
This article from Investing.com announces the filing of Form 4 for Northern Trust Corporation on July 2nd. It does not provide any further details regarding the contents of the Form 4 filing itself but is typical of a brief news announcement about regulatory filings. The article also includes various market data and other news headlines from Investing.com.
The Hess Retail Gasoline. Stable fuel pricing keeps this legacy product line relevant
Hess Retail Gasoline, though no longer a national chain, remains a significant regional offering in the US Northeast, tied to Hess Corporation's legacy branding and supply agreements. Despite Hess Corporation's pivot to upstream exploration and production after selling most retail assets in 2014, the stable pricing and perceived quality of Hess gasoline continue to appeal to consumers in specific markets. For investors, while direct revenue is modest, the legacy brand contributes to overall recognition and marketing efforts, showcasing how an energy company can maintain a consumer-facing product even after a major strategic shift.
What Does the Average Canadian’s TFSA Look Like at 55?
At age 55, a Tax-Free Savings Account (TFSA) becomes a significant retirement planning tool for Canadians. The average TFSA for individuals aged 55 to 59 had a fair market value of $37,600 in 2023, with an average unused contribution room of $52,972. The article highlights two Canadian stocks, North West Company (TSX:NWC) and Granite Real Estate Investment Trust (TSX:GRT.UN), as potential investments for long-term TFSA growth and steady income.
Home Bancorp to release Q2 2026 earnings on July 20 with a conference call on July 21
Home Bancorp, Inc. will release its financial results for the second quarter of 2026 after market close on July 20. The company will also host a conference call on July 21 at 10:30 a.m. CDT to discuss its performance. Investors can find more details on the company's investor relations website, as this announcement is crucial for those tracking Home Bancorp's financial health in its banking markets across Louisiana, Mississippi, and Texas.
Hour Loop (HOUR) director awarded 1,586 common shares as board compensation
Hour Loop (HOUR) director GAO MINGHUI was granted 1,586 common shares on July 1, 2026, as compensation for services rendered, according to a Form 4 SEC filing. This non-cash award, valued at $0.00 per share, increased the director's direct holdings to 30,594 shares. The transaction reflects board compensation practices rather than a change in trading sentiment.
Hilton Grand Vacations Appoints Carnival Cruise Line President Christine Duffy to Board of Directors
Hilton Grand Vacations Inc. (NYSE:HGV) has appointed Christine Duffy, President of Carnival Cruise Line, to its board of directors. Duffy brings over 30 years of leadership experience in the travel and hospitality industry, including expertise in operations, commercial strategy, and customer engagement. This appointment is expected to strengthen HGV's strategic positioning and operational excellence, potentially boosting investor confidence.
Form 4 Immunome Inc For: 2 July
The article reports on a Form 4 filing for Immunome Inc. on July 2nd, without providing specific details of the filing. It is a brief news item indicating an insider transaction or a change in ownership that has been disclosed. The stock symbol associated with Immunome Inc. is IMNM.
Immunome director Barchas sells $4.39m in common stock By Investing.com
Immunome Inc. director Isaac Barchas indirectly sold over $4.39 million worth of common stock across several transactions on June 30 and July 2, 2026, within a price range of $21.12 to $23.33 per share. These sales, executed via Rule 10b5-1 trading plans, occurred after the stock gained 167% over the past year and is considered overvalued by InvestingPro analysis, prompting him to lock in gains. Despite the insider selling, Wall Street analysts maintain a bullish outlook on Immunome, with price targets between $30 and $40, and the company has recently made significant advancements, including an NDA submission for varegacestat and a Phase 1 trial for IM-1617.
Grupo Financiero Galicia (GGAL) declares Ps.39.999B dividend in three installments
Grupo Financiero Galicia (GGAL) has declared a total cash dividend of Ps. 39,999,772,000, to be paid in three equal installments. The first installment of Ps. 13,333,257,333.33, equating to Ps. 8.3008 per share, is scheduled for payment between July 1 and July 15, 2026, with a record date of July 6, 2026. The dividend is subject to a 7% Argentine withholding tax and any Personal Asset Tax deductions.


